189 related articles for article (PubMed ID: 33253521)
1. Identification and Mechanistic Characterization of a Peptide Inhibitor of Glycogen Synthase Kinase (GSK3β) Derived from the Disrupted in Schizophrenia 1 (DISC1) Protein.
Saundh SL; Patnaik D; Gagné S; Bishop JA; Lipsit S; Amat S; Pujari N; Nambisan AK; Bigsby R; Murphy M; Tsai LH; Haggarty SJ; Leung AK
ACS Chem Neurosci; 2020 Dec; 11(24):4128-4138. PubMed ID: 33253521
[TBL] [Abstract][Full Text] [Related]
2. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
3. Effect of double mutations K214/A-E215/Q of FRATide on GSK3β: insights from molecular dynamics simulation and normal mode analysis.
Lu SY; Jiang YJ; Zou JW; Wu TX
Amino Acids; 2012 Jul; 43(1):267-77. PubMed ID: 21912861
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of kinase inactivation and nonbinding of FRATide to GSK3β due to K85M mutation: molecular dynamics simulation and normal mode analysis.
Lu S; Jiang Y; Lv J; Zou J; Wu T
Biopolymers; 2011 Oct; 95(10):669-81. PubMed ID: 21442609
[TBL] [Abstract][Full Text] [Related]
5. Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β.
Jurczyk A; Nowosielska A; Przewozniak N; Aryee KE; DiIorio P; Blodgett D; Yang C; Campbell-Thompson M; Atkinson M; Shultz L; Rittenhouse A; Harlan D; Greiner D; Bortell R
FASEB J; 2016 Feb; 30(2):983-93. PubMed ID: 26546129
[TBL] [Abstract][Full Text] [Related]
6. Opposing actions of the synapse-associated protein of 97-kDa molecular weight (SAP97) and Disrupted in Schizophrenia 1 (DISC1) on Wnt/β-catenin signaling.
Boccitto M; Doshi S; Newton IP; Nathke I; Neve R; Dong F; Mao Y; Zhai J; Zhang L; Kalb R
Neuroscience; 2016 Jun; 326():22-30. PubMed ID: 27026592
[TBL] [Abstract][Full Text] [Related]
7. Xanthone glucoside 2-β-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one binds to the ATP-binding pocket of glycogen synthase kinase 3β and inhibits its activity: implications in prostate cancer and associated cardiovascular disease risk.
Mangangcha IR; Brojen Singh RK; Lebeche D; Ali S
J Biomol Struct Dyn; 2022 Oct; 40(17):7868-7884. PubMed ID: 33769184
[TBL] [Abstract][Full Text] [Related]
8. GSK3β negatively regulates TRAX, a scaffold protein implicated in mental disorders, for NHEJ-mediated DNA repair in neurons.
Chien T; Weng YT; Chang SY; Lai HL; Chiu FL; Kuo HC; Chuang DM; Chern Y
Mol Psychiatry; 2018 Dec; 23(12):2375-2390. PubMed ID: 29298990
[TBL] [Abstract][Full Text] [Related]
9. DISC1 inhibits GSK3β activity to prevent tau hyperphosphorylation under diabetic encephalopathy.
Chen J; Liu Y; Zhou K; Zhang W; Wen B; Xu K; Liu Y; Chen L; Huang Y; He B; Hang W; Chen J
Biofactors; 2023 Jan; 49(1):173-184. PubMed ID: 36070513
[TBL] [Abstract][Full Text] [Related]
10. Theoretical Studies on the Selectivity Mechanisms of Glycogen Synthase Kinase 3β (GSK3β) with Pyrazine ATP-competitive Inhibitors by 3DQSAR, Molecular Docking, Molecular Dynamics Simulation and Free Energy Calculations.
Zhu J; Wu Y; Xu L; Jin J
Curr Comput Aided Drug Des; 2020; 16(1):17-30. PubMed ID: 31284868
[TBL] [Abstract][Full Text] [Related]
11. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling.
Mao Y; Ge X; Frank CL; Madison JM; Koehler AN; Doud MK; Tassa C; Berry EM; Soda T; Singh KK; Biechele T; Petryshen TL; Moon RT; Haggarty SJ; Tsai LH
Cell; 2009 Mar; 136(6):1017-31. PubMed ID: 19303846
[TBL] [Abstract][Full Text] [Related]
12. Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta.
Stoothoff WH; Bailey CD; Mi K; Lin SC; Johnson GV
J Neurochem; 2002 Nov; 83(4):904-13. PubMed ID: 12421363
[TBL] [Abstract][Full Text] [Related]
13. Prediction of the binding mode between GSK3β and a peptide derived from GSKIP using molecular dynamics simulation.
Tang XN; Lo CW; Chuang YC; Chen CT; Sun YC; Hong YR; Yang CN
Biopolymers; 2011 Jul; 95(7):461-71. PubMed ID: 21328310
[TBL] [Abstract][Full Text] [Related]
14. The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions.
Weng YT; Chien T; Kuan II; Chern Y
J Biomed Sci; 2018 Oct; 25(1):71. PubMed ID: 30285728
[TBL] [Abstract][Full Text] [Related]
15. Interactions of human truncated DISC1 proteins: implications for schizophrenia.
Newburn EN; Hyde TM; Ye T; Morita Y; Weinberger DR; Kleinman JE; Lipska BK
Transl Psychiatry; 2011 Aug; 1(8):e30. PubMed ID: 22832604
[TBL] [Abstract][Full Text] [Related]
16. Missense mutation in DISC1 C-terminal coiled-coil has GSK3β signaling and sex-dependent behavioral effects in mice.
Dachtler J; Elliott C; Rodgers RJ; Baillie GS; Clapcote SJ
Sci Rep; 2016 Jan; 6():18748. PubMed ID: 26728762
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling and molecular dynamics simulation studies of the GSK3β/ATP/substrate complex: understanding the unique P+4 primed phosphorylation specificity for GSK3β substrates.
Lu SY; Jiang YJ; Zou JW; Wu TX
J Chem Inf Model; 2011 May; 51(5):1025-36. PubMed ID: 21495724
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex.
Dajani R; Fraser E; Roe SM; Yeo M; Good VM; Thompson V; Dale TC; Pearl LH
EMBO J; 2003 Feb; 22(3):494-501. PubMed ID: 12554650
[TBL] [Abstract][Full Text] [Related]
19. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death.
Chen G; Bower KA; Ma C; Fang S; Thiele CJ; Luo J
FASEB J; 2004 Jul; 18(10):1162-4. PubMed ID: 15132987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
